Healthcare

The telehealth company Hims & Hers is navigating a period of significant executive transition, coinciding with substantial stock disposals by...

The future trajectory of Philip Morris International hinges on critical regulatory determinations from the U.S. Food and Drug Administration concerning...

Bristol-Myers Squibb has secured a significant regulatory milestone for its Alzheimer's drug candidate BMS-986446, receiving Fast Track designation from the...

Thermo Fisher Scientific may have found the catalyst needed to jumpstart its growth trajectory with a groundbreaking medical innovation. The...

In a significant strategic pivot, Walgreens Boots Alliance has confirmed plans to vacate its prominent corporate offices in Chicago's historic...

UnitedHealth Group, the American healthcare behemoth, finds itself navigating turbulent waters as conflicting signals emerge about its future trajectory. In...

A prolonged regulatory standoff with U.S. health authorities has concluded favorably for Ocugen. The biopharmaceutical company announced that the Food...

Medical technology firm Zynex is confronting a severe strategic crisis, prompting a dramatic shift in direction for its patient monitoring...

Wells Fargo delivered a surprising vote of confidence in Centene Corporation this Tuesday, dramatically raising its price target for the...

The investment case for telehealth provider Hims & Hers is facing increased scrutiny. Despite continuing to post robust growth, the...